| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.063 | 0.03 |